Trial reportPain2016
Open-label placebo treatment in chronic low back pain: a randomized controlled trial.
Trial report in Pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 6 registered trials, which are not on this map. Cited by 193 papers, 11 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Open-Label Placebo Treatment of Women With Premenstrual Syndrome: A Randomized Controlled Trial
Does the Subject's Understanding of Underlying Placebo Mechanisms Compensate for the Loss of Efficacy Associated With the Disclosure of the Use of a Placebo
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Subacute or Chronic Pain Pain: a Randomized Controlled Trial
Effectiveness of Conditioning + Open-label Placebo for the Management of Pain in Children Who Undergo Surgical Treatment of Idiopathic Scoliosis
Conditioning, Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy (PAO)
Who cites it
193 citing papers in PubMed, 11 syntheses or guidelines pooled it.
- Effects of open-label placebos across populations and outcomes: an updated systematic review and meta-analysis of randomized controlled trials.Scientific reports · 2025Pooled it
- A systematic review and meta analysis of open label placebo effects in chronic musculoskeletal pain.Scientific reports · 2025Pooled it
- Open label placebo for chronic low back pain: a systematic review and meta-analysis of randomized controlled trials.Pain management · 2025Pooled it
- Manual Therapy Effect in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022Pooled it
- Impact of contextual factors on patient outcomes following conservative low back pain treatment: systematic review.Chiropractic & manual therapies · 2022Pooled it
- Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis.Molecular psychiatry · 2022Pooled it
- Placebo effects in low back pain: A systematic review and meta-analysis of the literature.European journal of pain (London, England) · 2021 · on this mapPooled it
- Effects of open-label placebos in clinical trials: a systematic review and meta-analysis.Scientific reports · 2021Pooled it
- Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials.Frontiers in pain research (Lausanne, Switzerland) · 2021Pooled it
- The Influence of Placebo Effect on Craving and Cognitive Performance in Alcohol, Caffeine, or Nicotine Consumers: A Systematic Review.Frontiers in psychiatry · 2020Pooled it
- Placebo Economics: A Systematic Review About the Economic Potential of Utilizing the Placebo Effect.Frontiers in psychiatry · 2019Pooled it
- Dispositional optimism and open-label placebo responses in hair cortisol concentrations and psychological distress-A randomized controlled trial.Applied psychology. Health and well-being · 2026Trial
- The role of expectations and tailored feedback on the open-label Placebo effect.Journal of health psychology · 2026Trial
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial.Scientific reports · 2026Trial
- Predictive biomarkers of placebo response in patients with cancer: an exploratory analysis of the ABCD randomized clinical trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Trial
- Can Nocebo Effects Be Reduced via Open- and Closed-Label Counterconditioning?European journal of pain (London, England) · 2026Trial
- Open-Label Placebos as Adjunct for the Preventive Treatment of Migraine: A Randomized Clinical Trial.JAMA network open · 2025Trial
- Effectiveness of conditioning + open-label placebo for post-operative pain management in adolescent idiopathic scoliosis.Pain management · 2025Trial
- Open-label placebos reduce weight in obesity: a randomized controlled trial.Scientific reports · 2024Trial
- Open-Label Placebo Injection for Chronic Back Pain With Functional Neuroimaging: A Randomized Clinical Trial.JAMA network open · 2024Trial
133 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Erratum issuedErratum.2017
Authors and funding
6 authors.
Funding
Abstract
This randomized controlled trial was performed to investigate whether placebo effects in chronic low back pain could be harnessed ethically by adding open-label placebo (OLP) treatment to treatment as usual (TAU) for 3 weeks. Pain severity was assessed on three 0- to 10-point Numeric Rating Scales, scoring maximum pain, minimum pain, and usual pain, and a composite, primary outcome, total pain score. Our other primary outcome was back-related dysfunction, assessed on the Roland-Morris Disability Questionnaire. In an exploratory follow-up, participants on TAU received placebo pills for 3 additional weeks. We randomized 97 adults reporting persistent low back pain for more than 3 months' duration and diagnosed by a board-certified pain specialist. Eighty-three adults completed the trial. Compared to TAU, OLP elicited greater pain reduction on each of the three 0- to 10-point Numeric Rating Scales and on the 0- to 10-point composite pain scale (P < 0.001), with moderate to large effect sizes. Pain reduction on the composite Numeric Rating Scales was 1.5 (95% confidence interval: 1.0-2.0) in the OLP group and 0.2 (-0.3 to 0.8) in the TAU group. Open-label placebo treatment also reduced disability compared to TAU (P < 0.001), with a large effect size. Improvement in disability scores was 2.9 (1.7-4.0) in the OLP group and 0.0 (-1.1 to 1.2) in the TAU group. After being switched to OLP, the TAU group showed significant reductions in both pain (1.5, 0.8-2.3) and disability (3.4, 2.2-4.5). Our findings suggest that OLP pills presented in a positive context may be helpful in chronic low back pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.